Teligent Price to Free Cash Flow Ratio 2012-2021 | TLGT
Historical price to free cash flow ratio values for Teligent (TLGT) since 2012.
| Teligent Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2021-12-17 | 0.03 | 0.00 | |
| 2021-06-30 | 0.53 | $-0.26 | 0.00 |
| 2021-03-31 | 0.62 | $-1.92 | 0.00 |
| 2020-12-31 | 0.75 | $-2.48 | 0.00 |
| 2020-09-30 | 0.72 | $-5.29 | 0.00 |
| 2020-06-30 | 2.42 | $-4.50 | 0.00 |
| 2020-03-31 | 2.80 | $-4.13 | 0.00 |
| 2019-12-31 | 4.26 | $-4.94 | 0.00 |
| 2019-09-30 | 9.50 | $-3.67 | 0.00 |
| 2019-06-30 | 6.30 | $-5.38 | 0.00 |
| 2019-03-31 | 11.60 | $-6.16 | 0.00 |
| 2018-12-31 | 13.70 | $-7.20 | 0.00 |
| 2018-09-30 | 39.50 | $-8.40 | 0.00 |
| 2018-06-30 | 34.60 | $-9.07 | 0.00 |
| 2018-03-31 | 33.60 | $-8.81 | 0.00 |
| 2017-12-31 | 36.30 | $-7.51 | 0.00 |
| 2017-09-30 | 67.10 | $-6.87 | 0.00 |
| 2017-06-30 | 91.50 | $-5.86 | 0.00 |
| 2017-03-31 | 78.10 | $-4.51 | 0.00 |
| 2016-12-31 | 66.10 | $-3.22 | 0.00 |
| 2016-09-30 | 76.00 | $-4.47 | 0.00 |
| 2016-06-30 | 71.40 | $-2.62 | 0.00 |
| 2016-03-31 | 49.00 | $-3.12 | 0.00 |
| 2015-12-31 | 89.00 | $-3.21 | 0.00 |
| 2015-09-30 | 65.40 | $-0.88 | 0.00 |
| 2015-06-30 | 63.00 | $-1.62 | 0.00 |
| 2015-03-31 | 81.60 | $-0.78 | 0.00 |
| 2014-12-31 | 88.00 | $-0.74 | 0.00 |
| 2014-09-30 | 93.20 | $-0.15 | 0.00 |
| 2014-06-30 | 53.10 | $-0.12 | 0.00 |
| 2014-03-31 | 56.50 | $0.18 | 320.48 |
| 2013-12-31 | 30.50 | $-0.21 | 0.00 |
| 2013-09-30 | 18.20 | $-0.67 | 0.00 |
| 2013-06-30 | 14.30 | $-0.62 | 0.00 |
| 2013-03-31 | 17.10 | $-0.88 | 0.00 |
| 2012-12-31 | 10.40 | $-0.68 | 0.00 |
| 2012-09-30 | 12.40 | $-0.40 | 0.00 |
| 2012-06-30 | 10.30 | $-0.44 | 0.00 |
| 2012-03-31 | 10.90 | $-0.63 | 0.00 |
| 2011-12-31 | 11.50 | $-0.70 | 0.00 |
| 2011-09-30 | 11.00 | $-1.05 | 0.00 |
| 2011-06-30 | 11.10 | $-0.58 | 0.00 |
| 2011-03-31 | 15.30 | $-0.92 | 0.00 |
| 2010-12-31 | 16.80 | $-1.35 | 0.00 |
| 2010-09-30 | 15.10 | $-1.92 | 0.00 |
| 2010-06-30 | 10.10 | $-2.86 | 0.00 |
| 2010-03-31 | 7.10 | $-2.70 | 0.00 |
| 2009-12-31 | 7.80 | $-2.67 | 0.00 |
| 2009-09-30 | 10.40 | $-1.93 | 0.00 |
| 2009-06-30 | 11.50 | $-1.71 | 0.00 |
| 2009-03-31 | 6.90 | $-1.18 | 0.00 |
| 2008-12-31 | 4.80 | $-0.57 | 0.00 |
| 2008-09-30 | 13.20 | $-0.27 | 0.00 |
| 2008-06-30 | 23.50 | $0.10 | 241.77 |
| 2008-03-31 | 21.00 | $0.04 | 538.46 |
| 2007-12-31 | 14.10 | $-0.47 | 0.00 |
| 2007-09-30 | 10.00 | $-0.36 | 0.00 |
| 2007-06-30 | 7.50 | $-0.51 | 0.00 |
| 2007-03-31 | 8.50 | $-0.64 | 0.00 |
| 2006-12-31 | 11.60 | $-0.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |